by Mooslet Writing Services | Feb 11, 2016 | Big Pharma Lawsuits
Another GlaxoSmithKline lawsuit has just been filed. Did their drug cause a husband’s untimely death? When Wendy Dolin lost her husband Stewart to suicide, she decided to take action against the company that made a drug he had started taking only a few days prior....
by Mooslet Writing Services | Feb 9, 2016 | Big Pharma Business
Will a merger between two of the largest healthcare corporations create a pharmaceutical powerhouse? Pfizer announced its proposed purchase of Allergan in November of last year, a deal that could be worth $160 billion and one of the largest in history, surpassed only...
by Mooslet Writing Services | Feb 4, 2016 | Big Pharma Lawsuits
New Jersey-based pharmaceutical company Merck recently settled a federal class action lawsuit for $830 million. The Merck lawsuit had been brought to federal court by investors who had purchased company stock between May 21, 1999, and October 29, 2004. Former...
by Mooslet Writing Services | Feb 2, 2016 | Clinical Trials
In a proactive move, Janssen Pharmaceuticals announced on January 17 that they were voluntarily halting clinical trials of the experimental drug JNJ-42165279. According to Forbes, the experimental drug being tested is in a similar class of drugs which recently caused...
by Mooslet Writing Services | Jan 29, 2016 | Prescription Drugs
A pharmaceutical industry watchdog group says that a new GlaxoSmithKline (GSK) asthma medicine is too costly to justify its value for patients, according to Reuters. The nonprofit Institute for Clinical and Economic Review (ICER) found that Nucala, GSK’s newly...
by Mooslet Writing Services | Jan 29, 2016 | Big Pharma Lawsuits
A former employee of GlaxoSmithKline (GSK) has filed suit against the pharmaceutical giant, claiming he was fired without cause for whistleblowing. Alexandre Selmani, a research scientist who was employed by GSK until 2015, claims that he was fired for exposing...
by Chase Sagum | Oct 29, 2015 | FDA
Xarelto: Is Fatal Bleeding as Rare as the FDA Says? More than thirteen million people have been prescribed Xarelto since it was introduced in 2011. Along with Pradaxa and Eliquis, it has quickly replaced Coumadin as one of the most commonly prescribed blood thinners....
Recent Comments